Capstan Therapeutics was acquired by AbbVie in $2.1 billion deal.
02-25-23 Penn Med Campus (Mehak Dhaliwal)
Capstan Therapeutics was acquired by AbbVie in $2.1 billion deal. Mehak Dhaliwal
